Cost-utility analysis of newborn hepatitis B immunization in Beijing.
Yiwei GuoYong YangQian BaiZhengwei HuangZongwu WangDongxia CaiShuo LiXiaowei ManXuefeng ShiPublished in: Human vaccines & immunotherapeutics (2020)
Current universal hepatitis B vaccination program in Beijing was highly cost utility. The investment was reasonable for current universal vaccination program in Beijing.